How Has the Copovidone (PVP-VA) Market Evolved in Terms of Size and Value From 2026 to 2030?
The copovidone (PVP-VA) market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.18 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing demand for oral solid dosage drugs and generics, growing need for solubility enhancers for poorly water-soluble active ingredients, rising development of advanced drug-delivery systems requiring high-performance binders, and increasing use of copovidone in film-coated and controlled-release formulations.
The copovidone (PVP-VA) market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising growth in cosmetics and personal-care formulations using versatile polymers, increasing interest in multifunctional excipients for food, nutraceutical and industrial applications, growing regulatory acceptance and quality standards favouring copovidone, and increasing investments in novel formulations leveraging copovidone. Major trends in the forecast period include advancement in use of copovidone for poorly water-soluble drugs via hot-melt extrusion and spray-drying, innovation in controlled-release and solvent-free drug formulations, integration of copovidone in nutraceutical and cosmeceutical products, advancement of regulatory harmonisation facilitating global distribution, and innovation in multifunctional excipient blends combining copovidone with other polymers.
Get your free report sample today:
What Are the Major Drivers Propelling the Growth of the Copovidone (PVP-VA) Market?
The rising demand for biopharmaceuticals is expected to propel the growth of the copovidone (PVP-VA) market going forward. Biopharmaceuticals refer to therapeutic products that are produced using biological sources or biotechnology methods rather than traditional chemical synthesis. The increasing demand for biopharmaceuticals is due to the rising prevalence of chronic and complex diseases, which drives the need for advanced targeted therapies that conventional drugs cannot effectively treat. Copovidone (PVP-VA) supports biopharmaceuticals demand by providing versatile formulation and stabilizing properties, making it ideal for advanced drug delivery systems. It enhances drug solubility, stability, and bioavailability, improving overall therapeutic effectiveness and supporting the growing need for innovative biopharmaceutical products. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays rose 11.4% in 2023 to $449.7 billion, accelerating from 7.8% growth in 2022. Therefore, the rising demand for biopharmaceuticals is driving the growth of the copovidone (PVP-VA) market.
Increasing Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Rising Need For Effective Long-Term Disease Management
The increasing prevalence of chronic diseases is expected to propel the growth of the copovidone (PVP-VA) market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly over time, such as diabetes, heart disease, and arthritis, and often require ongoing medical attention and lifestyle management to control symptoms and prevent complications. Chronic diseases are increasing largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which raise the risk of conditions such as diabetes, heart disease, and obesity. Copovidone (PVP-VA) aids in chronic disease management by serving as a versatile pharmaceutical excipient that improves the stability, solubility, and bioavailability of medications. It enhances treatment efficacy by enabling more consistent drug delivery, supporting patient adherence, and facilitating the development of advanced drug formulations for long-term disease control. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the copovidone (PVP-VA) market.
How Is the Copovidone (PVP-VA) Market Structured Across Its Key Segment Categories?
The copovidone (pvp-va) market covered in this report is segmented –
1) By Type: Copovidone, PVP-VA 64, PVP-VA 73
2) By Product Form: Powder, Liquid
3) By Application: Pharmaceuticals, Cosmetics, Food And Beverage, Adhesives, Coatings
4) By Distribution Channel: Direct Sales, Distributors, Online Retailers
Subsegments:
1) By Copovidone: Direct Compression Grade, Wet Granulation Grade, Film-Forming Grade, Sustained-Release Applications, Immediate-Release Applications
2) By PVP-VA 64: Tablet Binding Applications, Film-Coating Applications, Granulation Applications, Solubility-Enhancement Uses, Hot-Melt Extrusion Applications
3) By PVP-VA 73: High-Viscosity Formulations, Controlled-Release Systems, Solid Dispersion Formulations, Capsule Filling Applications, Stabilization Of Active Ingredients
What Are the Key Industry Trends Driving Growth in the Copovidone (PVP-VA) Market?
Major companies operating in the copovidone (PVP-VA) market are focusing on developing advanced product grades and services, such as nitrite-tested grades, to boost regulatory compliance, enhance drug safety, and reduce nitrosamine risk. Nitrite-tested grades refer to advanced quality assurance services for excipients where each delivered batch is tested for nitrites, a potential precursor to nitrosamines with results documented on the Certificate of Analysis. For instance, in August 2025, BASF SE, a Germany-based chemical and materials company, launched Kollidon Nitrite Tested (NT) grades. This is an advanced service tier designed to support customers’ nitrosamine control strategies with enhanced nitrite testing and documentation for key products, including Kollidon VA 64 NT. The service provides nitrite tests on the respective product specification with results reported on the Certificate of Analysis (CoA) for all delivered batches, offering an additional layer of quality assurance and documentation.
Which Major Organizations Influence the Direction of the Copovidone (PVP-VA) Market?
Major companies operating in the copovidone (pvp-va) market are BASF SE, Ashland Global Holdings Inc., Hangzhou Motto Science & Technology Co. Ltd., JRS Pharma GmbH & Co. KG, Boai NKY Pharmaceuticals Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Luxi Group Co. Ltd., Zhongbao Chemicals Co. Ltd., Autech Industry Co. Ltd., Huangshan Bonsun Pharmaceuticals Co. Ltd., Ningbo Inno Pharmchem Co. Ltd., Shanghai Yuking Water Soluble Material Technology Co. Ltd., Tianjin YR Chemspec Technology Co. Ltd., Star-Tech Specialty Products Co. Ltd., JH Nanhang Life Sciences Co. Ltd., Huzhou Sunflower Specialty Polymer Co. Ltd., Jiaozuo Zhongwei Special Products Pharmaceutical Co. Ltd., Ulanqab Kema New Material Co. Ltd., Sunfair PCS Polymer Material (Nanjing) Co. Ltd., Hefei Trendchem Co. Ltd.
Get the detailed copovidone (pvp-va) market report today
Which Region Holds the Largest Share of the Copovidone (PVP-VA) Market?
North America was the largest region in the copovidone (PVP-VA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the copovidone (pvp-va) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment